Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure.
J Med Chem
; 65(10): 7324-7333, 2022 05 26.
Article
in En
| MEDLINE
| ID: mdl-35580334
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoplasmic Reticulum Calcium-Transporting ATPases
/
Heart Failure
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2022
Type:
Article
Affiliation country:
Italy